Drug Trial Radar · NCT03937882
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
700
Actual
Start
May 24, 2019
Primary completion
Nov 8, 2020
Study completion Oct 7, 2021
Sponsor
- Lead sponsor
- ReGenTree, LLCIndustry
- Sponsor type
- Industry
- First posted
- May 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to compare the safety and efficacy of RGN-259 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.
Conditions
- Dry Eye Syndromes
- Dry Eye
Interventions
RGN-259Drug
A preservative-free, sterile eye drop solution containing Thymosin beta 4 for direct instillation into each eye, four times a day (QID) for 14 days
PlaceboDrug
It is composed of the same excipients as RGN-259 but does not contain Thymosin beta 4
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Inferior Corneal Staining Change From Pre-CAE®(Controlled Adverse Environment) to Post-CAE® at Day 15 (Visit 4) Using the Ora Calibra® ScaleTime frame: Day 15
- Change From Baseline in Ocular Discomfort at Day 15 (Visit 4) Pre-CAE® Using the Ora Calibra® Ocular Discomfort & 4-Symptom QuestionnaireTime frame: Day 15
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona
Eye Research Foundation
Newport Beach, California
Vision Institute
Colorado Springs, Colorado
Dovilan Wyatt MD, LLC
Chicago, Illinois
Whitson Vision
Indianapolis, Indiana
Midwest Cornea Associates, LLC
Indianapolis, Indiana
The Eye Care Institute
Louisville, Kentucky
Andover Eye Associates
Andover, Massachusetts
Andover Eye Associates
Raynham, Massachusetts
Center For Sight
Henderson, Nevada
Oculus Research, Inc. at the Eye Care Center
Raleigh, North Carolina
Visual Eyes Optometric
Shelby, North Carolina
Bergstrom Eye Research, LLC
Fargo, North Dakota
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Andover Eye Associates
Warwick, Rhode Island
Total Eye Care, P.A.
Memphis, Tennessee
Texan Eye/Keystone Research
Austin, Texas
Mountain View Eye Center
Layton, Utah
Country Hills Eye Center
Ogden, Utah
Piedmont Eye Center
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.